1 mg
BioServUK offers a series of different monoclonal antibodies for the detection of the SARS-CoV-2 Spike. All antibodies come from hybridoma cell lines that were generated by immunization with the recombinant full-length Spike protein (S) or the receptor-binding domain.
This antibody has been validated by ELISA and is specifically directed against an epitope that is located on the RBD. It is produced exclusively under serum‐free conditions form hybridoma and purified through one-step purification with Protein-A affinity chromatography.